Literature DB >> 24496560

Factors influencing the failure of extracorporeal shock wave lithotripsy with Piezolith 3000 in the management of solitary ureteral stone.

Insang Hwang1, Seung-Il Jung, Kwang Ho Kim, Eu Chang Hwang, Ho Song Yu, Sun-Ouck Kim, Taek Won Kang, Dong Deuk Kwon, Kwangsung Park.   

Abstract

Studies of predictive factors of extracorporeal shockwave lithotripsy (ESWL) failure in patients with ureteral stones have not yielded results sufficient to prevent ESWL failure. The present study investigated patients with ureteral stone and analyzed the predictive factors of ESWL failure. Ninety patients with ureteral stone treated from January 2006 to June 2012 using ESWL for ureteral stone were enrolled. Patient's demographic data including age, gender, body mass index (BMI), symptoms and calculous characteristics including location, size, episode and the grade of hydronephrosis were recorded. Statistical results were performed using univariate and multivariate analyses for the predictive factors of ESWL failure. In univariate analysis, calculous location, size, and grade of hydronephrosis between two groups displayed significant differences (p < 0.05). The predictive factors of ESWL failure were BMI >25 kg/m(2) [Odds ratio (OR) = 3.5, 95% confidence interval (CI) 1.1-11.0], calculous size ≥ 1 cm (OR = 10.5, 95% CI 3.0-36.2), calculous location (mid-ureter; OR = 8.49, 95% CI 1.5-45.7) and severe grade of hydronephrosis (OR = 12.3, 95% CI 1.9-79.5). In conclusions, ESWL failure can be predicted in cases of obesity, calculous size exceeding 1 cm, mid-ureteral stone and severe hydronephrosis. When we consider calculous management in patients with these risk factors, initial surgical approach is recommended instead of ESWL.

Entities:  

Mesh:

Year:  2014        PMID: 24496560     DOI: 10.1007/s00240-014-0641-8

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  22 in total

1.  Extracorporeal shock wave lithotripsy versus ureteroscopy for distal ureteral calculi: a prospective randomized study.

Authors:  R Peschel; G Janetschek; G Bartsch
Journal:  J Urol       Date:  1999-12       Impact factor: 7.450

2.  Treatment of lower ureteral stones: extracorporeal shockwave lithotripsy or intracorporeal lithotripsy?

Authors:  H Biri; B Küpeli; K Isen; Z Sinik; U Karaoğlan; I Bozkirli
Journal:  J Endourol       Date:  1999-03       Impact factor: 2.942

3.  Does degree of hydronephrosis affect success of extracorporeal shock wave lithotripsy for distal ureteral stones?

Authors:  Ahmed el-Assmy; Ahmed R el-Nahas; Ramy F Youssef; Ahmed S el-Hefnawy; Khaled Z Sheir
Journal:  Urology       Date:  2007-03       Impact factor: 2.649

4.  Skin to stone distance is an independent predictor of stone-free status following shockwave lithotripsy.

Authors:  Trushar Patel; Kristin Kozakowski; Greg Hruby; Mantu Gupta
Journal:  J Endourol       Date:  2009-09       Impact factor: 2.942

5.  Predictive value of a new scoring system for the outcome of primary in situ experimental extracorporeal shock wave lithotripsy of upper ureteral calculi.

Authors:  S Ozgür; A Erol; Z Günes; I Dalva; S Cetin
Journal:  Eur Urol       Date:  1995       Impact factor: 20.096

6.  A clinical nomogram to predict the successful shock wave lithotripsy of renal and ureteral calculi.

Authors:  Joshua D Wiesenthal; Daniela Ghiculete; A Andrew Ray; R John D'A Honey; Kenneth T Pace
Journal:  J Urol       Date:  2011-08       Impact factor: 7.450

7.  Impact of hydronephrosis on treatment outcome of solitary proximal ureteral stone after extracorporeal shock wave lithotripsy.

Authors:  Hsi-Lin Hsiao; Shu-Pin Huang; Wen-Jeng Wu; Yung-Chin Lee; Wei-Ming Li; Yii-Her Chou; Ai-Wen Chang; Chun-Hsiung Huang; Shu-Chin Sun; Chia-Chu Liu
Journal:  Kaohsiung J Med Sci       Date:  2008-10       Impact factor: 2.744

8.  Optimal therapy for the distal ureteral stone: extracorporeal shock wave lithotripsy versus ureteroscopy.

Authors:  K R Anderson; D W Keetch; D M Albala; P S Chandhoke; B L McClennan; R V Clayman
Journal:  J Urol       Date:  1994-07       Impact factor: 7.450

9.  Extracorporeal shockwave lithotripsy for solitary distal ureteral stones: does the degree of urinary obstruction affect success?

Authors:  Murat Demirbas; Ahmet C Kose; Murat Samli; Cem Guler; Turgay Kara; Mustafa Karalar
Journal:  J Endourol       Date:  2004-04       Impact factor: 2.942

10.  Independent predictors of failure of shockwave lithotripsy for ureteral stones employing a second-generation lithotripter.

Authors:  Dimitrios Delakas; Ioannis Karyotis; George Daskalopoulos; Emmanuel Lianos; Emmanuel Mavromanolakis
Journal:  J Endourol       Date:  2003-05       Impact factor: 2.942

View more
  5 in total

1.  The Influence of Pain on the Outcome of Extracorporeal Shockwave Lithotripsy.

Authors:  Elke Bovelander; Saskia Weltings; Mandana Rad; Paulien van Kampen; Rob C M Pelger; Hossain Roshani
Journal:  Curr Urol       Date:  2019-03-08

2.  Impact of ureteric stent on outcome of extracorporeal shockwave lithotripsy: A propensity score analysis.

Authors:  Krystian Kaczmarek; Adam Gołąb; Marcin Słojewski
Journal:  Cent European J Urol       Date:  2016-04-08

3.  Machine learning prediction of stone-free success in patients with urinary stone after treatment of shock wave lithotripsy.

Authors:  Seung Woo Yang; Yun Kyong Hyon; Hyun Seok Na; Long Jin; Jae Geun Lee; Jong Mok Park; Ji Yong Lee; Ju Hyun Shin; Jae Sung Lim; Yong Gil Na; Kiwan Jeon; Taeyoung Ha; Jinbum Kim; Ki Hak Song
Journal:  BMC Urol       Date:  2020-07-03       Impact factor: 2.264

4.  Effect of urine pH on the effectiveness of shock wave lithotripsy: A pilot study.

Authors:  Ahmad Majzoub; Ammar Al-Ani; Tawiz Gul; Hatem Kamkoum; Khalid Al-Jalham
Journal:  Urol Ann       Date:  2016 Jul-Sep

Review 5.  Retrograde intrarenal surgery: An expanding role in treatment of urolithiasis.

Authors:  María Rodríguez-Monsalve Herrero; Steeve Doizi; Etienne Xavier Keller; Vincent De Coninck; Olivier Traxer
Journal:  Asian J Urol       Date:  2018-06-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.